Article
Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHD
2024-05-02
Abstract excerpt
Allogeneic hematopoietic cell transplantation (allo-HCT) is the main therapeutic approach for patients with high-risk acute myeloid leukemia (AML), but the rate of relapse remains high and is associated with poor outcomes. Discovering new approaches to maximize the graft-versus-leukemia (GVL) effects while mitigating graft-versus-host disease (GVHD) should therefore be pursued. Because of the difficulties in model...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 76aa8e8a-5692-5d5a-9804-63118a29d382
- DOI
- 10.1101/2024.04.30.591828
